Ticker Scout
← tickerscout.ai

The Coca-Cola Company (KO)

CIK 0000021344 · NYSE · Latest period: Q3 FY2026 (ended 2026-10-02, 10-Q accession 0001628280-26-067844) · Annual report: FY2025 10-K (filed 2026-02-20, accession 0001628280-26-010047) · Next expected filing: 10-K ~2027-02-19

PeriodQ3 FY2026Q2 FY2026

Published

MetricAmountvs. year ago
Revenue$13,380,000,000up 7.4%
Net income$4,009,000,000up 8.5%
Diluted EPS$0.93up 8.1%
Operating income$4,465,000,000up 12.1%

Company details

NameCoca Cola Co
TickerKO
CIK0000021344
ExchangeNYSE
StateGeorgia
IncorporationDelaware
SIC2080
OfficeManufacturing
IndustryBeverages
Latest period coveredQ3 FY2026, ended 2026-10-02, 10-Q, accession 0001628280-26-067844
Fiscal year end12/31 (MM/DD)
Next expected filing10-K around 2027-02-19 (predicted)

AI synthesis of six filings for The Coca-Cola Company

Fiscal year ends December 31. Third quarter 2026 ended October 2, 2026 (third quarter 2025 ended September 26, 2025). All amounts are in US dollars as reported.

Business

From the Form 10-K for fiscal 2025 (year ended December 31, 2025), accession 0001628280-26-010047.

Coca-Cola is a total beverage company that owns or licenses and markets beverage brands sold in more than 200 countries and territories. It earns most of its money by selling beverage concentrates and syrups to bottling partners, mostly independent companies, which add water and sweeteners, package the drinks and sell them to retailers. A smaller but revenue-heavy part of the business sells finished beverages directly, mainly through company-owned bottlers. Beverages bearing the company's trademarks account for 2.2 billion of the estimated 65 billion servings of all beverages consumed worldwide each day. Net operating revenues were $47,941 million in 2025, of which $28.8 billion came from outside the United States.

Two lines of business.

  • Concentrate operations sell concentrates, syrups (including fountain syrups) and certain finished beverages to authorized bottlers. These sit inside the four geographic segments and carry the higher gross margins.
  • Finished product operations sell finished beverages to retailers, distributors and wholesalers, mainly through the company's consolidated bottlers (the Bottling Investments segment). They generate more revenue but lower gross margins than concentrate sales. Costa retail coffee stores, which sell directly to consumers, also fall here and are reported in EMEA.

Pricing model. In most markets the company uses incidence-based concentrate pricing: the concentrate price moves with bottler pricing, the channels the finished drinks are sold in, and package mix, so the company and its bottlers share in price and mix gains. Bottlers must buy all of their concentrate or syrup for the covered brands from the company or its approved suppliers. Most U.S. bottlers operate under 10-year renewable Comprehensive Beverage Agreements, which require mandatory incidence pricing and a binding national governance model.

Brands and categories. The company groups its portfolio into Trademark Coca-Cola; sparkling flavors; water, sports, coffee and tea; juice, value-added dairy and plant-based beverages; and emerging beverages.

  • Sparkling soft drinks include Coca-Cola, Diet Coke/Coca-Cola Light, Coca-Cola Zero Sugar, Fanta, Fresca, Schweppes (owned in certain countries outside the U.S.), Sprite and Thums Up.
  • Water, sports, coffee and tea include Aquarius, Ayataka, BODYARMOR, Ciel, Costa, Dasani, Fuze Tea, Georgia, smartwater, vitaminwater, Gold Peak, I LOHAS, Powerade and Topo Chico.
  • Juice, dairy and plant-based brands include Core Power, Del Valle, fairlife, innocent, Maaza, Minute Maid and Simply. fairlife provides most of the company's dairy revenue.
  • Certain Coca-Cola bottlers distribute Monster Energy under distribution coordination agreements with Monster Beverage. The company also sells ready-to-drink alcohol products outside the U.S. and, in the U.S., through a firewalled subsidiary.

Segments. The company reports five operating segments plus Corporate. Their shares of 2025 net operating revenues were:

  • North America: 40.8% (40.1% in 2024)
  • EMEA (Europe, Middle East and Africa, including Costa and innocent since the Global Ventures segment was folded in on January 1, 2025): 22.6% (21.8%)
  • Latin America: 13.2% (13.8%)
  • Bottling Investments (all consolidated bottlers, wherever located): 12.0% (13.2%)
  • Asia Pacific: 11.1% (10.9%)
  • Corporate: 0.3% (0.2%)

Profitability ranks differently from revenue. Segment operating margins in 2025 were 59.1% in Latin America, 39.7% in EMEA, 38.3% in Asia Pacific, 25.9% in North America and 7.4% in Bottling Investments. North America's margin absorbed the $960 million BodyArmor trademark impairment.

Scale and concentration. The Coca-Cola system sold 33.8 billion unit cases in 2025 (33.7 billion in 2024). Sparkling soft drinks were 69% of worldwide unit case volume and Trademark Coca-Cola 47%. The United States accounted for 16% of volume. Mexico, China, Brazil and India together accounted for 33%. The five largest independent bottlers by 2025 volume handled 44% of worldwide unit case volume: Coca-Cola FEMSA, Coca-Cola Europacific Partners (CCEP), Coca-Cola HBC (CCHBC), Arca Continental and Swire Coca-Cola. One bottler alone accounted for 10% of 2025 net operating revenues, reported in the EMEA and Asia Pacific segments.

Bottling strategy. The company takes control of bottlers from time to time, often in underperforming markets, and later refranchises them to independent partners. Since 2024 it has refranchised its bottling operations in the Philippines, Bangladesh and several territories in India. In 2025 it sold its finished product operations in Nigeria and its stake in Coca-Cola Consolidated. In July 2025 it sold a 40% noncontrolling interest in its Indian bottling operations to a local partner for approximately $1.3 billion. It has also agreed to sell a controlling stake in its African bottler (see Subsequent events and pending transactions).

Other facts. The company had approximately 65,900 employees at December 31, 2025 (69,700 a year earlier; the drop came mainly from 2025 divestitures). About 8,900 of them were in the United States. Its principal competitor in many countries is PepsiCo. Other significant competitors include Nestlé, Keurig Dr Pepper, Danone, Suntory, Anheuser-Busch InBev, Kirin, Heineken, Diageo and Red Bull, along with private-label brands. Ready-to-drink sales are seasonal, peaking in the second and third calendar quarters.

Risk factors

From the Form 10-K for fiscal 2025, accession 0001628280-26-010047, Item 1A and Item 3. The third-quarter 2026 Form 10-Q (accession 0001628280-26-067844) adds no new risk factors. Its updates to the legal matters are included below.

The IRS transfer-pricing dispute is the largest single financial exposure. The IRS rejected, for 2007–2009, a methodology it had agreed with the company in 1996 and audited across five cycles. It reallocated over $9 billion of income from foreign licensees to the U.S. parent.

  • Tax Court. The Tax Court largely sided with the IRS in 2020 and 2023 and in August 2024 entered a decision of $2.7 billion of additional tax, or $6.0 billion with interest. The company paid that $6.0 billion in September 2024 as a deposit. It would be refunded, in full or in part, with interest, if the company wins on appeal.
  • Appeal. The company appealed to the U.S. Court of Appeals for the Eleventh Circuit, which heard the case on June 25, 2026. The company says an October 2025 Eighth Circuit ruling in the separate 3M case is "highly supportive" of its position on the Brazilian blocked-income issue. It continues to judge it more likely than not that it will prevail, and its tax reserve stood at $538 million at October 2, 2026.
  • If it loses. It would forfeit the deposit and $589 million of accrued interest receivable. It estimates further tax and interest of approximately $14 billion for 2010–2025, as of December 31, 2025. That exposure grew by roughly $450 million in the third quarter of 2026 and $1.4 billion over the first nine months. Applying the Tax Court's method in 2026 would increase the effective tax rate by approximately 3.8%.

Bottler dependence. Most revenue comes from selling concentrate to independent bottlers that make their own decisions. The company's ability to raise concentrate prices can be limited by bottlers' finances. A weaker major bottler would hit both concentrate revenue and, where the company holds equity stakes, equity income, and could lead to impairments. Refranchising deals may not close on good terms, and divestitures may remove revenue that is hard to replace.

Health, ingredients and regulation.

  • Health concerns. Concern about obesity, sugar and processed foods, U.S. federal and state initiatives on childhood chronic disease, the use of weight-loss drugs, and possible changes to programs such as SNAP may reduce demand for sweetened drinks.
  • Taxes and labelling. Sugar and packaging taxes, ingredient bans, and labelling or warning rules (such as California's Proposition 65) could raise costs, force reformulation or reduce sales.
  • Specific substances. Public concern over sweeteners, synthetic colours, 4-MEI in caramel colouring, BPA in can linings and PFAS in packaging could shift consumers away from some products.

Costs and supply chain. The company and its bottlers are exposed to the prices and availability of sweeteners (HFCS, sugar, sucralose), juices, milk, PET, aluminium, energy and transport. Some inputs come from few or single suppliers. The company expects inflationary pressure on certain costs to continue in 2026, and price increases taken to offset costs may reduce volume.

Currency and macro. In 2025, currency movements including hedging cut operating income by 12% and net operating revenues by 2%. The company also cites risks from geopolitical conflict, product boycotts, tariffs and sanctions, and currency restrictions in emerging markets, where much of its growth is expected.

Impairment. Recently acquired intangibles are most at risk. BodyArmor's trademark was written down by $760 million in 2024 and $960 million in the fourth quarter of 2025. At October 2, 2026 its fair value approximated its $2,440 million carrying value, so the company says a further charge is likely if the brand misses its revised projections or discount rates rise.

Competition and channels. Retailer consolidation, discounters, private labels and the growth of e-commerce pressure prices and promotional spending. Failure to innovate, digitalize the system or manage new product launches (including alcohol) could cost market share.

Cybersecurity and data privacy. The company and its bottlers depend on information systems that are regular targets of attack, and bottlers and acquired businesses often run separate systems. Expanding privacy and data-localization laws raise compliance costs and the risk of fines. On July 16, 2026 the company disclosed that its fairlife dairy subsidiary had identified unauthorized third-party access to its systems in a ransomware event, which temporarily suspended fairlife's U.S. production; Canadian production was not affected (Form 8-K, accession 0001628280-26-048466). The forward-looking statements in the July 28, 2026 second-quarter release refer to "the recent unauthorized access incident experienced at fairlife" (accession 0001628280-26-049922). Neither the third-quarter Form 10-Q (accession 0001628280-26-067844), whose risk-factor item refers back to the 2025 10-K, nor the October 27, 2026 earnings release (accession 0001628280-26-067403) mentions the incident.

Sustainability, packaging and water. Plastic-waste concerns, extended producer responsibility and deposit laws, water scarcity and climate change could raise costs and reduce demand. The company faces plastic-pollution lawsuits from Baltimore, Los Angeles County and the U.S. Virgin Islands. Baltimore's remaining public nuisance claim was dismissed on July 22, 2026; the city filed a notice of appeal on all claims on August 18, 2026. The company also faces both pro-sustainability and "anti-ESG" scrutiny.

Talent, labour and productivity. Competition for specialized talent, collective-bargaining renewals, strikes at the company's or bottlers' plants, and disruption from productivity programs could affect operations.

Management's discussion of fiscal 2025

From the Form 10-K for fiscal 2025, accession 0001628280-26-010047, Item 7.

Revenue. Net operating revenues rose 2% to $47,941 million from $47,061 million. Concentrate sales volume added 1 point and price/mix 4 points. Currency took off 2 points, as a stronger dollar against the Mexican and Argentine pesos, Ethiopian birr and Turkish lira outweighed a weaker dollar against the euro, pound, rand and yen. Acquisitions and divestitures took off 1 point. Worldwide unit case volume was even: EMEA grew 3%, North America fell 1%, and Latin America and Asia Pacific were even. Bottling Investments volume fell 8%, reflecting the refranchisings in the Philippines, Bangladesh and India; excluding those, it was even. By segment, revenue rose 5% in EMEA, 4% in North America and 1% in Asia Pacific. It fell 2% in Latin America, where 11 points of price/mix (including inflationary pricing in Argentina) were outweighed by 12 points of currency. Bottling Investments revenue fell 8%.

Margins and costs. Gross margin improved to 61.6% from 61.1%, helped by pricing and by the prior-year refranchising of bottling operations in the Philippines, Bangladesh and India, partly offset by currency and higher commodity costs. SG&A was roughly flat at $14,521 million, and advertising rose to $5.4 billion from $5.1 billion.

Operating income. Operating income rose 38% to $13,762 million, and operating margin rose to 28.7% from 21.2%. The jump came mainly because other operating charges fell to $1,261 million from $4,163 million. The 2024 figure had included a $3,109 million remeasurement of the fairlife contingent consideration. The 2025 charges were dominated by the $960 million BodyArmor impairment. Segment operating income was:

  • North America: $5,070 million (up from $4,556 million)
  • EMEA: $4,298 million ($4,255 million)
  • Latin America: $3,742 million ($3,792 million; a 21% currency hit)
  • Asia Pacific: $2,042 million ($2,156 million)
  • Bottling Investments: $426 million ($496 million)
  • Corporate's operating loss narrowed to $1,816 million from $5,263 million.

Below the operating line. Equity income rose 15% to $2,031 million. Other income was $1,073 million. That figure included a $1,952 million gain on selling the Coca-Cola Consolidated stake, a $331 million gain on a partial CCEP sale and a $102 million India refranchising gain. Against these were a $1,274 million charge on classifying the African bottling operations as held for sale and a $393 million charge on the Nigeria sale. The effective tax rate was 17.9% (18.6% in 2024). Net income attributable to shareowners was $13,107 million, or $3.04 per diluted share, versus $10,631 million, or $2.46.

Cash and capital. Operating cash flow was $7,408 million, up from $6,805 million. Each year was depressed by a one-off payment: 2025 included $6.1 billion of the $6.2 billion final fairlife milestone payment, and 2024 included the $6.0 billion IRS deposit. Capital expenditures were $2,112 million. Dividends paid were $8,779 million, and share repurchases under the 2019 plan totalled 9.4 million shares for $634 million. The company also received $1,338 million from selling a noncontrolling interest (the India bottling stake). At year-end the company held $15.8 billion of cash, short-term investments and marketable securities and had $6.2 billion of unused backup credit lines. Long-term debt was rated A+ (S&P) and A1 (Moody's). In February 2026 the board raised the quarterly dividend to $0.53 a share, the 64th consecutive annual increase. Management guided to about $2.2 billion of 2026 capital expenditures and to buybacks sized to offset employee-equity dilution.

Management's framing. Management names six strategic challenges: obesity and health concerns; changing consumer preferences; competition and the digital marketplace; product safety and quality; sustainability; and talent. Its growth pillars are a portfolio of loved brands, transformed marketing and innovation, optimizing the Coca-Cola ecosystem, talent and capabilities, and its "license to win." It expects to keep raising prices to offset most inflation over time.

Current quarter: third quarter 2026

From the Form 10-Q for the quarter ended October 2, 2026, accession 0001628280-26-067844, and the third-quarter earnings release furnished as Exhibit 99.1 to the Form 8-K filed October 27, 2026, accession 0001628280-26-067403. Organic revenue, comparable EPS and free cash flow are the company's non-GAAP measures as defined in that release.

Demand was broad-based. Unit case volume grew 5% in the quarter, led by India, China, Mexico and Brazil. Concentrate sales grew 6%, or 7% excluding divestitures, running about 2 points ahead of unit case volume because of shipment timing. By segment:

  • Latin America: volume up 6%, with Mexico +3%, Brazil +6%, Peru +26% and Colombia +17%.
  • Asia Pacific: volume up 6%. India and Southwest Asia rose 17%, while Japan and South Korea fell 5%.
  • EMEA: volume up 5%, with growth across Eurasia and Middle East, Africa and Europe.
  • North America: volume even. Trademark Coca-Cola grew 2% but water, sports, coffee and tea fell 4%.
  • Bottling Investments: volume up 8%, on India and Africa.

By category, Coca-Cola Zero Sugar grew 16%, and fairlife was among the growth contributors in juice and dairy.

Revenue. Net operating revenues rose 7% to $13,380 million from $12,455 million. Volume added 7 points, price/mix 1 point and currency 1 point, while divestitures took off 1 point. Organic revenue grew 7%. Price/mix was held back by unfavourable mix: Asia Pacific's price/mix was −2 points, and North America's pricing was partly offset by mix. Latin America revenue rose 25%, helped by 9 points of currency.

Margins. Gross margin widened to 63.2% from 61.5% on pricing, currency, commodity cost stabilization and the sale of the Nigerian finished product operations. SG&A rose 10% to $3,975 million as advertising increased to $1,777 million from $1,523 million and incentive accruals rose on timing. Other operating charges fell to $10 million from $58 million. Operating income rose 12% to $4,465 million, and operating margin was 33.4% versus 32.0%. Currency added about 3 points to operating income growth.

Segment operating income (third quarter 2026 versus 2025):

  • North America: $1,766 million vs $1,681 million
  • EMEA: $1,171 million vs $1,097 million
  • Latin America: $1,152 million vs $897 million, including a 14% currency benefit
  • Asia Pacific: $563 million vs $521 million
  • Bottling Investments: $205 million vs $57 million
  • Corporate's loss widened to $392 million from $271 million

Below the operating line. Other income was a $155 million loss. Most of it was a $167 million settlement loss and $25 million of special termination benefits from the buy-out of a non-U.S. defined benefit pension plan. The effective tax rate rose to 16.1% from 11.9%. The prior-year quarter had carried $442 million of discrete tax benefits, against $172 million this quarter. Net income attributable to shareowners was $4,009 million versus $3,696 million, and diluted EPS rose 8% to $0.93 from $0.86. Comparable EPS rose 11% to $0.91, including a 2-point currency tailwind.

Nine months. Revenue rose 9% to $39,232 million, operating income rose 13% to $13,496 million, and diluted EPS was $2.86 versus $2.51. Asia Pacific was the weak spot: nine-month operating income slipped to $1,755 million from $1,792 million, as price/mix fell 6 points on mix and affordability initiatives despite 10% concentrate growth.

Cash and balance sheet. Operating cash flow for the nine months was $12,471 million, against $3,652 million a year earlier, when it was reduced by $6,069 million of the fairlife milestone payment. The improvement also reflected the receivables factoring program, lower tax payments and working capital. Free cash flow was $11.4 billion. The company repaid $3,165 million of debt and had no commercial paper outstanding at October 2, 2026, against $1,495 million at year-end. It repurchased 10.0 million shares under its plan for $787 million (average cost $78.77) and paid $6,842 million of dividends; this year the full third-quarter dividend was paid within the quarter. It held $16.6 billion of cash, short-term investments and marketable securities, with $6.6 billion of unused backup credit lines.

Outlook. With these results the company raised its full-year 2026 guidance, to organic revenue growth of at least 5% and comparable EPS growth of at least 11%. The fourth quarter of 2026 has six fewer days than the fourth quarter of 2025, which the company says will affect fourth-quarter financial results. Unit case volume growth is not affected, because it is measured on average daily sales.

Subsequent events and pending transactions

From the Form 10-Q for the quarter ended October 2, 2026, accession 0001628280-26-067844 (Notes 2 and 9; Part I, Item 2), and the October 27, 2026 earnings release, accession 0001628280-26-067403. The name of the African bottler and the structure of the sale are from the third-quarter 2025 earnings release, accession 0001628280-25-045577.

The 10-Q contains no separate subsequent-events note and discloses no acquisitions, divestitures or financings completed after October 2, 2026. The items below are those disclosed after the quarter or still pending at the filing date.

  • Dividend. At its October 2026 meeting the board approved the regular quarterly dividend of $0.53 per share, payable December 15, 2026 to shareowners of record on December 1, 2026.
  • African bottling sale (pending). In October 2025 the company agreed to sell a controlling interest in its African bottling operations, Coca-Cola Beverages Africa, to Coca-Cola HBC AG, an equity method investee. CCHBC also has an option to buy the company's remaining 25% within six years of closing. Neither the 10-K nor the 10-Q discloses a purchase price. Closing still requires regulatory approvals; the 10-Q expects it by the end of 2026, and guidance assumes the fourth quarter. The business will be deconsolidated on closing.
  • Southeast Asian bottlers (pending). During the third quarter, the company's bottling operations in Singapore, Malaysia and Myanmar met held-for-sale criteria. They were carried at book value because expected proceeds less costs exceeded it. The 10-Q names no buyer or price and expects closings, subject to regulatory approvals, by mid-2027.
  • IRS appeal. The Eleventh Circuit heard the company's appeal on June 25, 2026, and no decision had been disclosed as of the 10-Q filing.

AI synthesis of events in 13 filings

Filings that contain financial statements

The earnings press releases furnished as Exhibit 99.1 to these Form 8-Ks carry condensed consolidated statements of income, balance sheets, statements of cash flows and operating-segment tables, in millions of US dollars:

  • Form 8-K filed October 27, 2026, accession 0001628280-26-067403: three and nine months ended October 2, 2026 (compared with the periods ended September 26, 2025). Income statements for both periods, the balance sheet at October 2, 2026 (compared with December 31, 2025), the nine-month cash flow statement, and segment tables.
  • Form 8-K filed July 28, 2026, accession 0001628280-26-049922: three and six months ended July 3, 2026. Income statements, balance sheet, six-month cash flow statement, and segment tables.
  • Form 8-K filed April 28, 2026, accession 0001628280-26-027723: three months ended April 3, 2026. Income statement, balance sheet, cash flow statement, and segment table.
  • Form 8-K filed February 10, 2026, accession 0001628280-26-006642: three months and full year ended December 31, 2025. Income statements, balance sheet, full-year cash flow statement, and segment tables.
  • Form 8-K filed October 21, 2025, accession 0001628280-25-045577: three and nine months ended September 26, 2025 (the prior-year comparison period), with the same set of statements.

Earnings and guidance

  • October 27, 2026 (third quarter 2026; accession 0001628280-26-067403). Coca-Cola reported third-quarter results and raised full-year guidance. Net operating revenues grew 7% to $13,380 million, and organic revenues (non-GAAP) grew 7%. Unit case volume grew 5%. Operating income grew 12% to $4,465 million, and operating margin was 33.4% (32.0% a year earlier). Diluted EPS was $0.93 (up 8%), and comparable EPS (non-GAAP) was $0.91 (up 11%). Year-to-date cash from operations was $12.5 billion and free cash flow (non-GAAP) was $11.4 billion.
  • Full-year 2026 guidance, as raised on October 27, 2026 (prior guidance from July 28, 2026 in parentheses):
    • Organic revenue growth of at least 5% (approximately 5%).
    • Comparable EPS (non-GAAP) growth of at least 11% (9% to 10%), including an approximate 3% currency tailwind and an approximate 1% headwind from acquisitions and divestitures.
    • Comparable currency-neutral EPS excluding acquisitions and divestitures growth of at least 9% (7% to 8%).
    • Free cash flow (non-GAAP) of at least $13.0 billion (approximately $12.4 billion), consisting of at least $15.2 billion of cash from operations and approximately $2.2 billion of capital expenditures.
    • Underlying effective tax rate of 19.7% (19.9%), which excludes the effect of the ongoing IRS tax litigation if the company were not to prevail.
  • Fourth quarter and 2027 considerations (same release). The company expects an approximate 4% headwind to comparable net revenues and an approximate 3% headwind to comparable EPS from acquisitions and divestitures in the fourth quarter. For full-year 2027 it flags an approximate 8% headwind to comparable net revenues and an approximate 2% headwind to comparable EPS from acquisitions and divestitures, and it will give 2027 guidance with fourth-quarter results.
  • July 28, 2026 (second quarter 2026; accession 0001628280-26-049922). Second-quarter net revenues grew 7%, organic revenues grew 6%, unit case volume grew 5%, and EPS was $1.03 (comparable EPS $0.97, up 11%). Full-year guidance was raised: organic revenue growth to approximately 5% (from 4% to 5%), comparable EPS growth to 9% to 10% (from 8% to 9%), and free cash flow to approximately $12.4 billion (from approximately $12.2 billion).
  • April 28, 2026 (first quarter 2026; accession 0001628280-26-027723). First-quarter net revenues grew 12% and organic revenues grew 10%. EPS was $0.91 and comparable EPS was $0.86 (up 18%). Full-year comparable EPS growth guidance was raised to 8% to 9% (from 7% to 8%). The release notes the first quarter had six more days than the first quarter of 2025.
  • February 10, 2026 (fourth quarter and full year 2025; accession 0001628280-26-006642). Full-year 2025 net revenues grew 2% and organic revenues grew 5%. Full-year EPS was $3.04 (up 23%) and comparable EPS was $3.00 (up 4%). Cash flow from operations was $7.4 billion. The fourth quarter included a $960 million non-cash impairment of the BODYARMOR trademark. The remaining share repurchase authorization was approximately $5.2 billion. Initial 2026 guidance was organic revenue growth of 4% to 5%, comparable EPS growth of 7% to 8%, and free cash flow of approximately $12.2 billion.

Divestitures and portfolio

  • Sale of bottling operations in Africa: signed, not closed. The sale was agreed in October 2025 (a definitive agreement to sell a portion of the company's interest in its Africa bottling operations to Coca-Cola HBC AG, with an option for CCHBC to acquire the remaining 25% within six years of closing). The October 27, 2026 release (accession 0001628280-26-067403) describes the sale as "pending," subject to regulatory approvals, and its guidance assumes closing during the fourth quarter of 2026. That is a later date than in the July release, which assumed closing towards the end of the third quarter or during the fourth quarter. The related assets and liabilities are classified as held for sale. The company recorded reductions of $5 million (third quarter) and $61 million (nine months) to the impairment previously recorded on these operations.
  • Other held-for-sale operations. The quarterly report for the period ended October 2, 2026 (Form 10-Q, accession 0001628280-26-067844) states that the Singapore, Malaysia and Myanmar bottling operations met held-for-sale criteria during the third quarter, with closings subject to regulatory approvals and expected by mid-2027. Total assets and liabilities held for sale across the Africa and Singapore, Malaysia and Myanmar disposal groups were $6,275 million and $3,003 million at October 2, 2026 (Note 2 of the 10-Q; at December 31, 2025, Africa only: $5,342 million and $2,570 million).
  • Completed earlier: the October 2025 sale of the Nigeria finished product operations and the May 2025 refranchising of certain India bottling territories are referenced in the release as structural changes affecting revenue comparisons (accession 0001628280-26-067403).

Cybersecurity incident

  • July 16, 2026 (Form 8-K, Item 8.01; accession 0001628280-26-048466). Coca-Cola announced that its fairlife, LLC dairy subsidiary identified unauthorized third-party access to part of its systems, including production-related systems, in a ransomware event. Production operations at fairlife in the United States were temporarily suspended; Canadian production was not affected. The company said product quality and safety were not impacted, that it had notified law enforcement, and that it had not yet determined whether the incident was reasonably likely to materially affect the company. The company filed no follow-up Form 8-K on the incident through the October 27, 2026 earnings release, and neither that release nor the third-quarter Form 10-Q mentions it.

Leadership and governance

  • December 10, 2025 (accession 0001552781-25-000454). The board elected Henrique Braun, Chief Operating Officer, as Chief Executive Officer effective March 31, 2026, with James Quincey moving to Executive Chairman on that date.
  • January 14, 2026 (accession 0001552781-26-000017). The company announced a new Chief Digital Officer role (Sedef Salingan Sahin), and moved customer and commercial leadership to Manolo Arroyo (Chief Marketing and Customer Commercial Officer), both effective March 31, 2026. John Murphy remains President and Chief Financial Officer.
  • February 20, 2026 (accession 0001628280-26-010052). Compensation letters confirmed Mr. Braun's base salary of $1,450,000 and Mr. Quincey's of $1,200,000 from March 31, 2026, each with a 200% target annual incentive.
  • June 25, 2026 (accession 0001552781-26-000366). Jennifer Mann, President of the North America Operating Unit, will step down effective July 31, 2026 and serve as a senior advisor until April 30, 2027. From August 1, 2026, John Murphy assumes responsibility for North America on an interim basis.
  • October 16, 2025 (accession 0001628280-25-045223). Max Levchin was elected a director and joined the Talent and Compensation Committee.
  • April 29, 2026 annual meeting (Form 8-K filed May 1, 2026; accession 0001628280-26-029230). All directors were elected, with Thomas Gayner receiving the lowest support at 76.00%. Say-on-pay was approved with 90.84% of votes cast, and Ernst & Young LLP was ratified as auditor with 93.56%.

Tax litigation

  • The October 27, 2026 release and the Form 10-Q (accessions 0001628280-26-067403 and 0001628280-26-067844) continue to carry the guidance caveat for the ongoing U.S. IRS tax litigation. The 10-Q states the company paid $6.0 billion in response to IRS invoices issued in September 2024, with related accrued interest receivable of $589 million at October 2, 2026, and that it would not recover those amounts if the IRS positions were upheld.

Financials

Figures link to the filing they came from. Wherever the SEC filing tags a number, that number is linked: click it and the filing opens at the exact line that prints it. A figure with no link was either derived by AI, such as a margin, free cash flow or a trailing-twelve-month total, or taken from a filing that does not tag its numbers, such as an earnings release.

About this file

TickerKO
CIK0000021344
CompanyThe Coca-Cola Company
Business typeconsumer staples (beverage concentrate and finished-goods manufacturer)
Schema templatestandard
Reporting currencyUSD
Converted to USDno
Unitsactual dollars (not millions)

KO annual income statement, balance sheet and cash flow

Taken from the SEC filings and normalized to actual dollars.

FY2025FY2024FY2023
Period start2025-01-012024-01-012023-01-01
Period end2025-12-312024-12-312023-12-31
Period typefiscal yearfiscal yearfiscal year
Source accession10-K10-K10-K
Income statement
Revenue47,941,000,00047,061,000,00045,754,000,000
Cost of goods sold18,397,000,00018,324,000,00018,520,000,000
Gross profit29,544,000,00028,737,000,00027,234,000,000
Selling general and administrative expenses14,521,000,00014,582,000,00013,972,000,000
Other operating charges1,261,000,0004,163,000,0001,951,000,000
Operating income13,762,000,0009,992,000,00011,311,000,000
Interest income786,000,000988,000,000907,000,000
Interest expense1,654,000,0001,656,000,0001,527,000,000
Equity income net2,031,000,0001,770,000,0001,691,000,000
Other income net1,073,000,0001,992,000,000570,000,000
Income before income taxes15,998,000,00013,086,000,00012,952,000,000
Income taxes2,861,000,0002,437,000,0002,249,000,000
Consolidated net income13,137,000,00010,649,000,00010,703,000,000
Net income attributable to noncontrolling interests30,000,00018,000,000-11,000,000
Net income13,107,000,00010,631,000,00010,714,000,000
Basic EPS3.052.472.48
Diluted EPS3.042.462.47
Basic shares4,303,000,0004,309,000,0004,323,000,000
Diluted shares4,313,000,0004,320,000,0004,339,000,000
Dividends declared per share2.041.941.84
Balance sheet
Cash and cash equivalents10,270,000,00010,828,000,000
Short term investments3,602,000,0002,020,000,000
Total cash and short term investments13,872,000,00012,848,000,000
Marketable securities1,934,000,0001,723,000,000
Trade accounts receivable net3,038,000,0003,569,000,000
Inventories4,425,000,0004,728,000,000
Prepaid expenses and other current assets2,433,000,0002,998,000,000
Assets held for sale5,342,000,000131,000,000
Total current assets31,044,000,00025,997,000,000
Equity method investments20,235,000,00018,087,000,000
Deferred income tax assets1,206,000,0001,319,000,000
Property plant and equipment net9,613,000,00010,303,000,000
Trademarks with indefinite lives12,531,000,00013,301,000,000
Goodwill15,491,000,00018,139,000,000
Other noncurrent assets14,696,000,00013,403,000,000
Total assets104,816,000,000100,549,000,000
Accounts payable and accrued expenses14,813,000,00021,712,000,000
Loans and notes payable1,551,000,0001,499,000,000
Current maturities of long term debt1,822,000,000648,000,000
Accrued income taxes525,000,0001,387,000,000
Liabilities held for sale2,570,000,0003,000,000
Total current liabilities21,281,000,00025,249,000,000
Long term debt42,119,000,00042,375,000,000
Other noncurrent liabilities4,735,000,0004,084,000,000
Deferred income tax liabilities2,406,000,0002,469,000,000
Equity attributable to shareowners32,169,000,00024,856,000,000
Noncontrolling interests2,106,000,0001,516,000,000
Total equity34,275,000,00026,372,000,000
Total debt45,492,000,00044,522,000,000
Total liabilities70,541,000,00074,177,000,000
Cash flow
Depreciation and amortization1,050,000,0001,075,000,0001,128,000,000
Stock based compensation expense279,000,000286,000,000254,000,000
Operating cash flow7,408,000,0006,805,000,00011,599,000,000
Capex-2,112,000,000-2,064,000,000-1,852,000,000
Investing cash flow-67,000,0002,524,000,000-3,349,000,000
Issuances of stock313,000,000747,000,000539,000,000
Purchases of stock for treasury-746,000,000-1,795,000,000-2,289,000,000
Dividends paid-8,779,000,000-8,359,000,000-7,952,000,000
Financing cash flow-8,140,000,000-6,910,000,000-8,310,000,000
Free cash flow5,296,000,0004,741,000,0009,747,000,000

KO quarterly income statement, balance sheet and cash flow

Taken from the SEC filings and normalized to actual dollars.

Q3 FY2026Q3 FY2025
Period start2026-07-042025-06-28
Period end2026-10-022025-09-26
Period typethree monthsthree months
Source accession10-Q10-Q
Income statement
Revenue13,380,000,00012,455,000,000
Cost of goods sold4,930,000,0004,797,000,000
Gross profit8,450,000,0007,658,000,000
Selling general and administrative expenses3,975,000,0003,618,000,000
Other operating charges10,000,00058,000,000
Operating income4,465,000,0003,982,000,000
Interest income224,000,000185,000,000
Interest expense354,000,000391,000,000
Equity income net653,000,000644,000,000
Other income net-155,000,000-237,000,000
Income before income taxes4,833,000,0004,183,000,000
Income taxes777,000,000500,000,000
Consolidated net income4,056,000,0003,683,000,000
Net income attributable to noncontrolling interests47,000,000-13,000,000
Net income4,009,000,0003,696,000,000
Basic EPS0.930.86
Diluted EPS0.930.86
Basic shares4,303,000,0004,303,000,000
Diluted shares4,314,000,0004,313,000,000
Dividends declared per share0.530.51
Balance sheet
Cash and cash equivalents13,454,000,000
Short term investments231,000,000
Total cash and short term investments13,685,000,000
Marketable securities2,910,000,000
Trade accounts receivable net3,571,000,000
Inventories4,410,000,000
Prepaid expenses and other current assets2,475,000,000
Assets held for sale6,275,000,000
Total current assets33,326,000,000
Equity method investments20,710,000,000
Deferred income tax assets1,086,000,000
Property plant and equipment net9,485,000,000
Trademarks with indefinite lives12,459,000,000
Goodwill15,408,000,000
Other noncurrent assets15,476,000,000
Total assets107,950,000,000
Accounts payable and accrued expenses15,633,000,000
Loans and notes payable73,000,000
Current maturities of long term debt4,923,000,000
Accrued income taxes577,000,000
Liabilities held for sale3,003,000,000
Total current liabilities24,209,000,000
Long term debt36,623,000,000
Other noncurrent liabilities4,678,000,000
Deferred income tax liabilities2,907,000,000
Equity attributable to shareowners37,372,000,00031,247,000,000
Noncontrolling interests2,161,000,0002,020,000,000
Total equity39,533,000,00033,267,000,000
Total debt41,619,000,000
Total liabilities68,417,000,000
Cash flow
Depreciation and amortization253,000,000268,000,000
Operating cash flow4,928,000,0005,043,000,000
Capex-379,000,000-479,000,000
Free cash flow4,549,000,0004,564,000,000
Investing cash flow57,000,0001,255,000,000
Financing cash flow-4,011,000,000-3,140,000,000
Dividends paid-2,280,000,000-2,108,000,000

KO year-to-date income statement and cash flow

Taken from the SEC filings and normalized to actual dollars.

Nine months ended October 2, 2026Nine months ended September 26, 2025
Period start2026-01-012025-01-01
Period end2026-10-022025-09-26
Period typenine monthsnine months
Source accession10-Q10-Q
Income statement
Revenue39,232,000,00036,119,000,000
Cost of goods sold14,515,000,00013,674,000,000
Gross profit24,717,000,00022,445,000,000
Selling general and administrative expenses11,167,000,00010,322,000,000
Other operating charges54,000,000202,000,000
Operating income13,496,000,00011,921,000,000
Interest income644,000,000553,000,000
Interest expense1,098,000,0001,223,000,000
Equity income net1,641,000,0001,556,000,000
Other income net236,000,000229,000,000
Income before income taxes14,919,000,00013,036,000,000
Income taxes2,459,000,0002,215,000,000
Consolidated net income12,460,000,00010,821,000,000
Net income attributable to noncontrolling interests102,000,000-15,000,000
Net income12,358,000,00010,836,000,000
Basic EPS2.872.52
Diluted EPS2.862.51
Basic shares4,302,000,0004,303,000,000
Diluted shares4,313,000,0004,314,000,000
Dividends declared per share1.591.53
Cash flow
Depreciation and amortization783,000,000814,000,000
Stock based compensation expense194,000,000204,000,000
Operating cash flow12,471,000,0003,652,000,000
Capex-1,063,000,000-1,230,000,000
Investing cash flow1,161,000,000977,000,000
Issuances of stock355,000,000243,000,000
Purchases of stock for treasury-900,000,000-644,000,000
Dividends paid-6,842,000,000-4,391,000,000
Financing cash flow-10,546,000,000-3,088,000,000
Free cash flow11,408,000,0002,422,000,000

KO trailing twelve month income statement and cash flow

Derived by AI from the figures the filings report. No filing prints these, so none of them is linked.

Twelve months ended October 2, 2026
Period start2025-09-27
Period end2026-10-02
Period typetrailing twelve months
Source accession10-Q
Income statement
Revenue51,054,000,000
Cost of goods sold19,238,000,000
Gross profit31,816,000,000
Selling general and administrative expenses15,366,000,000
Other operating charges1,113,000,000
Operating income15,337,000,000
Interest income877,000,000
Interest expense1,529,000,000
Equity income net2,116,000,000
Other income net1,080,000,000
Income before income taxes17,881,000,000
Income taxes3,105,000,000
Consolidated net income14,776,000,000
Net income attributable to noncontrolling interests147,000,000
Net income14,629,000,000
Basic EPS3.4
Diluted EPS3.39
Dividends declared per share2.1
Cash flow
Depreciation and amortization1,019,000,000
Operating cash flow16,227,000,000
Capex-1,945,000,000
Free cash flow14,282,000,000

Adjustments

Splits appliednone
ADR ration/a
FXnone; The Coca-Cola Company reports in U.S. dollars

Notes

  • All figures come from The Coca-Cola Company's Form 10-K for fiscal 2025 (accession 0001628280-26-010047) and its Form 10-Q for the quarter ended October 2, 2026 (accession 0001628280-26-067844), with six-month cash flow amounts from the company's second-quarter 2026 results furnished on Form 8-K (accession 0001628280-26-049922). All of these statements are presented in millions of U.S. dollars; every figure here has been restated in actual dollars.
  • The company labels its top line “Net Operating Revenues”; it is carried here as `revenue`. “Net Income Attributable to Shareowners of The Coca-Cola Company” is carried as `net_income`, and the pre-minority-interest total is carried separately as `consolidated_net_income`. Earnings per share are calculated by the company on the shareowner-attributable figure.
  • Coca-Cola's fiscal year ends December 31, but its first three interim quarters end on the Friday closest to the calendar quarter end. The third quarter of 2026 therefore ended October 2, 2026 and the comparable 2025 quarter ended September 26, 2025; the period dates shown are the ones the filings state.
  • The FY2025 10-K presents three years of income statement and cash flow (2025, 2024 and 2023) but only two balance sheet dates (December 31, 2025 and 2024), so no balance sheet is reported here for fiscal 2023.
  • Coca-Cola's balance sheet does not print a total liabilities subtotal. Total liabilities shown here is total assets less total equity. Total debt is the sum of the three borrowing lines the balance sheet does print: loans and notes payable, current maturities of long-term debt, and long-term debt.
  • The company does not present a free cash flow line. Free cash flow here is net cash provided by operating activities less purchases of property, plant and equipment.
  • The 10-Q presents its cash flow statement for the nine months only. The quarterly cash flow figures for the quarters ended October 2, 2026 and September 26, 2025 are therefore the nine-month amounts in the 10-Q less the six-month amounts the company reported in its second-quarter 2026 results furnished on Form 8-K (accession 0001628280-26-049922), which show the six months ended July 3, 2026 alongside the six months ended June 27, 2025. Cash flow items reported for the quarters are operating cash flow, capital expenditure, free cash flow, dividends paid, depreciation and amortization, and the investing and financing totals; the remaining lines are shown only for the nine-month and full-year periods.
  • The 10-Q balance sheet shows October 2, 2026 and December 31, 2025 only, so no balance sheet is presented for the year-ago quarter. Total equity and equity attributable to noncontrolling interests at September 26, 2025 are taken from the changes-in-equity note; equity attributable to shareowners is the difference between the two.
  • In July 2025 the company sold a 40% noncontrolling interest in its bottling operations in India for approximately $1.3 billion, which, net of direct costs, increased total equity by $1.1 billion, of which $644 million was allocated to equity attributable to noncontrolling interests. That sale falls inside the quarter ended September 26, 2025.
  • Dividends per share are the amounts stated in the dividend line captions of the statement of shareowners' equity (fiscal years) and the changes-in-equity note (quarters and nine-month periods).
  • The trailing-twelve-month view covers September 27, 2025 through October 2, 2026 and is fiscal 2025 plus the first nine months of 2026 less the first nine months of 2025. Its earnings and dividends per share are the sum of the per-share amounts the company reported for those component periods; weighted share counts are not additive across periods and are therefore not shown on that basis. Its cash flow figures are limited to operating cash flow, capital expenditure, free cash flow, and depreciation and amortization.
  • Operating cash flow for the nine months ended September 26, 2025 ($3,652 million) and for fiscal 2025 ($7,408 million) is held down by the final fairlife milestone payment: $6,069 million of the $6,173 million payment, made during the nine months ended September 26, 2025, ran through operating activities. That payment sits outside the trailing-twelve-month window, which is why trailing operating cash flow ($16,227 million) is far above fiscal 2025's.
  • Fiscal 2024 operating income was held down by $4,163 million of other operating charges, of which $3,109 million was the remeasurement of the fairlife contingent consideration liability and $760 million the impairment of the BodyArmor trademark. Fiscal 2025 charges of $1,261 million included a further $960 million BodyArmor trademark impairment, and fiscal 2023 charges of $1,951 million included $1,702 million of fairlife contingent consideration remeasurement. Comparisons of operating income across these three years are dominated by those items.
  • The company had no stock splits in the period covered, is not an American depositary receipt issuer, and reports in U.S. dollars, so no split, depositary-ratio or currency adjustment has been applied.

Uncertainties

  • The quarterly cash flow figures for the quarters ended October 2, 2026 and September 26, 2025 are arithmetic differences rather than amounts the company printed. The nine-month totals are from the 10-Q; the six-month amounts subtracted from them are from the second-quarter 2026 results furnished on Form 8-K, which is a results announcement rather than a quarterly report.
  • No balance sheet is available for the quarter ended September 26, 2025 beyond total equity and noncontrolling interests, so total assets, debt and the remaining balance sheet lines are absent for that period.
  • No balance sheet is available for fiscal 2023, because the FY2025 10-K carries only two balance sheet dates.
  • Trailing-twelve-month earnings per share is the sum of the per-share amounts reported for fiscal 2025 and the two nine-month periods; because weighted average share counts differ slightly between those periods, it can differ by roughly a cent from trailing net income divided by a current share count.
  • Assets held for sale were $6,275 million at October 2, 2026, up from $5,342 million at December 31, 2025 and $131 million at December 31, 2024, and liabilities held for sale were $3,003 million. Balance sheet comparisons across those dates are affected by that reclassification.

Company details

NameCoca Cola Co
TickerKO
CIK0000021344
ExchangeNYSE
StateGeorgia
IncorporationDelaware
SIC2080
OfficeManufacturing
IndustryBeverages

Fiscal period

Fiscal year2026
Fiscal periodQ3
TagFY26Q3
Period end2026-10-02
Form10-Q
Accession0001628280-26-067844
Fiscal year end1231
Sourcefacts

Source filings

RoleCurrentFormFiscal yearFiscal periodTagPeriod endFiledAccessionSource
annualno10-K2025FYFY252025-12-312026-02-200001628280-26-010047reported
quarterlyyes10-Q2026Q3FY26Q32026-10-022026-10-280001628280-26-067844facts

Related companies

See every covered company and its filings data.

Not investment advice, see the Disclaimer.